AAmerican Journal of Psychiatry3/18/2026Comment on Esketamine 5 Years After Approval: Welcome New Data With Continuing QuestionsMuhammad Ahmed·Gerard Sanacora·Mai Himedan·Patricia Cabrera·Ibrahim Turkoz·Teodora Doherty·David M. KernRead at American Journal of PsychiatryTagsTreatment of Major DepressionPharmacology
